Parallax Volatility Advisers, L.P. Karuna Therapeutics, Inc. Transaction History

Parallax Volatility Advisers, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$161.01 - $317.85 $23,829 - $47,041	148 New	148 $46,000
Q4 2022 Feb 14, 2023	BUY	$191.53 - $236.82 $6.17 Million - $7.63 Million	32,199 Added 1065.13%	35,222 $6.92 Million
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $374,217 - $838,640	3,023 New	3,023 $680,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.